A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Running, not enrolling · Not applicable

Conditions studied: Proximal Femoral Metastases

In brief

The purpose of this study is to look at two different types of surgeries regularly used for treating cancer that has spread to and weakened the thigh bone (femur). Because it is not known which of these surgeries is best, the investigators will compare the results of the two procedures. They are looking to see if differences exist (after surgery) in function, quality of life, pain control, and possible complications.

Key facts

Study ID

NCT02164019

Run by

Memorial Sloan Kettering Cancer Center

People needed

73

Starts

2014-06-01

Expected to finish

2027-06-01

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Surgeon's estimated survival ≥ 1 month
• Patients presenting for orthopaedic evaluation with a painful impending pathologic femur fracture or displaced pathologic femur fracture in the intertrochanteric, pertrochanteric, or subtrochanteric region of the proximal femur. The anatomic region of interest is defined by a line drawn from the base of the femoral neck to 5 cm below the base of the lesser trochanter or 2 diaphyseal shaft widths, whichever is greater.
• Patients with an impending fracture who have had bevacizumab are eligible provided there will be a 3-week window between their last infusion and surgery.
• Diagnosis of widespread visceral and/or osseous metastatic disease based on clinical and radiographic evidence. (Patients may continue on study if surgery shows a non-malignant process.)
• All cancer diagnoses, except lymphoma, will be eligible

You may not qualify if…

• Estimated survival <1 month
• A large soft tissue mass or other disease involving an area outside of the defined pertrochanteric anatomic region described above. (Patients excluded based on intraoperative findings will be replaced on the study.)
• Prior surgical treatment of the area (i.e., revision cases). A biopsy does not constitute prior surgical treatment.
• Radiographic evidence of an intramedullary occlusion by blastic metastases that would necessitate an alternative method of treatment, such as a plate/screw construct.
• Diagnosis of lymphoma
• Age < 18 years
• Patients with advanced hip arthritis on radiographic imaging
• Previous randomization for a contralateral procedure as part of this study

Where it is running

• Spectrum Health Medical Group — Grand Rapids, Michigan, United States
• Memorial Sloan Kettering Cancer Center 1275 York Avenue — New York, New York, United States
• University of Rochester Medical Center — Rochester, New York, United States
• SUNY Upstate Medical University — Syracuse, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Duke University — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.